April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
IL-4 Stimulates Macrophage Soluble Flt-1 Production and IL-4 Administration Inhibits Laser-induced CNV in Mice
Author Affiliations & Notes
  • Wei-Kang Wu
    Clinical Science at South Bristol,
    University of Bristol, Bristol, United Kingdom
  • Lindsay B. Nicholson
    Clinical Science at South Bristol,
    Cellular and Molecular Medicine,
    University of Bristol, Bristol, United Kingdom
  • Dave O. Bates
    Physiology and Pharmacology,
    University of Bristol, Bristol, United Kingdom
  • Andrew D. Dick
    Clinical Science at South Bristol,
    Cellular and Molecular Medicine,
    University of Bristol, Bristol, United Kingdom
  • Footnotes
    Commercial Relationships  Wei-Kang Wu, None; Lindsay B. Nicholson, None; Dave O. Bates, None; Andrew D. Dick, None
  • Footnotes
    Support  National Eye Research Centre
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2302. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wei-Kang Wu, Lindsay B. Nicholson, Dave O. Bates, Andrew D. Dick; IL-4 Stimulates Macrophage Soluble Flt-1 Production and IL-4 Administration Inhibits Laser-induced CNV in Mice. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2302.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Activation and infiltration of myeloid derived cells participates in retinal angiogenesis and is central to tissue remodeling. Their exact role during pathological angiogenesis remains undefined. Murine macrophages activated by Th2 cytokines (IL-4 and IL-13) display anti-angiogenic properties, notably increasing soluble VEGF receptor-1 (sFlt-1)/ VEGF ratio in vitro. To understand whether there is an inhibitory role for IL-4 in vivo we studied its administration in laser-induced choroidal neovascularization (LI-CNV).

Methods: : Bone marrow derived macrophages (BMDMs) were conditioned with either IL-4 (20U/ml) or IL-13 (20U/ml, M2 signature) or PGE2 (50ng/ml, pro-angiogenic; VEGFhi M2 signature), and sFlt-1 mRNA and protein expression were determined. Macrophage sFlt-1-mediated VEGF neutralization was confirmed by a modified binding assay. HUVEC proliferation was estimated by alamarBlue staining to assess the bioactivity of sFlt-1 induced by IL-4 or IL-13, and specificity of sFlt-1 inhibition was confirmed following sFlt-1 siRNA knockdown as well in cytokine-depleted culture conditions. The model of LI-CNV in C57BL/6 mice was used to examine whether intravitreal administration of 0.6µg IL-4 per eye inhibits angiogenesis.

Results: : IL-4 or IL-13-induced macrophage sFlt-1 expression (23.4±1.3 fold). Specific sFlt-1 binding to VEGF and inhibition of HUVEC proliferation was observed in IL-4 or IL-13-conditioned media and specificity confirmed through the absence of response following sFlt-1 knockdown. IL-4, IL-13 and PGE2 all generate M2 macrophages (arginase-1hi). However, PGE2 conditioning increased VEGF (2.72±0.32 fold) which was reduced by IL-4 (to 12.4±4.6%) or IL-13 (to 52.5±5.9%), and IL-4 or IL-13-induced sFlt-1 production was inhibited by PGE2 (to 12.0±1.8%). Angiogenesis was decreased in IL-4 treated eyes following LI-CNV. To confirm IL-4 effect, administration of 20µg per eye anti-IL-4 mAb increased CNV area.

Conclusions: : We have shown that IL-4 and IL-13 induce macrophage sFlt-1 and inhibit PGE2-mediated pro-angiogenic property of macrophages. IL-4 administration inhibits angiogenesis, and IL-4 neutralization during CNV increases neovascularization, suggesting that endogenous IL-4 plays a role limiting vessel growth.

Keywords: age-related macular degeneration • choroid: neovascularization • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×